IRIS Accounts Production v26.1.10.61 06509477 Board of Directors 30.12.24 29.12.25 29.12.25 4/6/2026 true false true false false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 06509477 2024-12-29 06509477 2025-12-29 06509477 2024-12-30 2025-12-29 06509477 2023-12-29 06509477 2023-12-30 2024-12-29 06509477 2024-12-29 06509477 ns15:EnglandWales 2024-12-30 2025-12-29 06509477 ns14:PoundSterling 2024-12-30 2025-12-29 06509477 ns10:Director1 2024-12-30 2025-12-29 06509477 ns10:PrivateLimitedCompanyLtd 2024-12-30 2025-12-29 06509477 ns10:SmallEntities 2024-12-30 2025-12-29 06509477 ns10:Audited 2024-12-30 2025-12-29 06509477 ns10:SmallCompaniesRegimeForDirectorsReport 2024-12-30 2025-12-29 06509477 ns10:SmallCompaniesRegimeForAccounts 2024-12-30 2025-12-29 06509477 ns10:FullAccounts 2024-12-30 2025-12-29 06509477 1 2024-12-30 2025-12-29 06509477 ns10:OrdinaryShareClass1 2024-12-30 2025-12-29 06509477 ns10:Director2 2024-12-30 2025-12-29 06509477 ns10:Director3 2024-12-30 2025-12-29 06509477 ns10:RegisteredOffice 2024-12-30 2025-12-29 06509477 ns5:CurrentFinancialInstruments 2025-12-29 06509477 ns5:CurrentFinancialInstruments 2024-12-29 06509477 ns5:Non-currentFinancialInstruments 2025-12-29 06509477 ns5:Non-currentFinancialInstruments 2024-12-29 06509477 ns5:ShareCapital 2025-12-29 06509477 ns5:ShareCapital 2024-12-29 06509477 ns5:SharePremium 2025-12-29 06509477 ns5:SharePremium 2024-12-29 06509477 ns5:RetainedEarningsAccumulatedLosses 2025-12-29 06509477 ns5:RetainedEarningsAccumulatedLosses 2024-12-29 06509477 ns5:ComputerSoftware 2024-12-30 2025-12-29 06509477 ns5:IntangibleAssetsOtherThanGoodwill 2024-12-29 06509477 ns5:IntangibleAssetsOtherThanGoodwill 2024-12-30 2025-12-29 06509477 ns5:IntangibleAssetsOtherThanGoodwill 2025-12-29 06509477 ns5:IntangibleAssetsOtherThanGoodwill 2024-12-29 06509477 ns5:LeaseholdImprovements 2024-12-29 06509477 ns5:PlantMachinery 2024-12-29 06509477 ns5:FurnitureFittings 2024-12-29 06509477 ns5:ComputerEquipment 2024-12-29 06509477 ns5:LeaseholdImprovements 2024-12-30 2025-12-29 06509477 ns5:PlantMachinery 2024-12-30 2025-12-29 06509477 ns5:FurnitureFittings 2024-12-30 2025-12-29 06509477 ns5:ComputerEquipment 2024-12-30 2025-12-29 06509477 ns5:LeaseholdImprovements 2025-12-29 06509477 ns5:PlantMachinery 2025-12-29 06509477 ns5:FurnitureFittings 2025-12-29 06509477 ns5:ComputerEquipment 2025-12-29 06509477 ns5:LeaseholdImprovements 2024-12-29 06509477 ns5:PlantMachinery 2024-12-29 06509477 ns5:FurnitureFittings 2024-12-29 06509477 ns5:ComputerEquipment 2024-12-29 06509477 ns5:CostValuation 2024-12-29 06509477 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-12-29 06509477 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-12-29 06509477 ns5:Non-currentFinancialInstruments 2024-12-30 2025-12-29 06509477 ns10:OrdinaryShareClass1 2025-12-29

REGISTERED NUMBER: 06509477 (England and Wales)

SCINOMED LTD

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 29 DECEMBER 2025

SCINOMED LTD (REGISTERED NUMBER: 06509477)

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 29 DECEMBER 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 4 |

SCINOMED LTD

COMPANY INFORMATION

FOR THE YEAR ENDED 29 DECEMBER 2025

| DIRECTORS: | Mr A P Lane

| Mr M Hauck

| Mr J Simkins

| REGISTERED OFFICE: | Windsor House

| Cornwall Road

| Harrogate

| HG1 2PW

| REGISTERED NUMBER: | 06509477 (England and Wales)

| AUDITORS: | DSC Accountants Ltd

| Chartered Accountants

| Statutory Auditors

| Tattersall House

| East Parade

| Harrogate

| North Yorkshire

| HG1 5LT

SCINOMED LTD (REGISTERED NUMBER: 06509477)

BALANCE SHEET

29 DECEMBER 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Intangible assets | 4 | 440,037 |  | 543,570 |  |

Tangible assets | 5 | 398,656 |  | 456,000 |  |

Investments | 6 | 1,965,656 |  | 1,965,656 |  |

2,804,349 |  | 2,965,226 |  |

CURRENT ASSETS

Stocks | 18,432 |  | 1,073,055 |  |

Debtors | 7 | 12,885,386 |  | 9,121,602 |  |

Prepayments and accrued income | 377,379 |  | 683,122 |  |

Cash at bank | 44,720 |  | 101,764 |  |

13,325,917 |  | 10,979,543 |  |

CREDITORS

Amounts falling due within one year | 8 | 218,355 |  | 460,259 |  |

NET CURRENT ASSETS | 13,107,562 |  | 10,519,284 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 15,911,911 |  | 13,484,510 |  |

CREDITORS

Amounts falling due after more than one year | 9 | (26,455,817 | ) | (24,323,373 | ) |

ACCRUALS AND DEFERRED INCOME | (86,019 | ) | (120,249 | ) |

NET LIABILITIES | (10,629,925 | ) | (10,959,112 | ) |

CAPITAL AND RESERVES

Called up share capital | 10 | 800,000 |  | 800,000 |  |

Share premium | 5,715,000 |  | 5,715,000 |  |

Retained earnings | (17,144,925 | ) | (17,474,112 | ) |

SHAREHOLDERS' FUNDS | (10,629,925 | ) | (10,959,112 | ) |

SCINOMED LTD (REGISTERED NUMBER: 06509477)

BALANCE SHEET - continued

29 DECEMBER 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 June 2026 and were signed on its behalf by:

Mr A P Lane - Director

SCINOMED LTD (REGISTERED NUMBER: 06509477)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 29 DECEMBER 2025

1. | STATUTORY INFORMATION

| Scinomed Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Preparation of consolidated financial statements

| The financial statements contain information about Scinomed Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

| Going concern

| At the balance sheet date, the company had net liabilities of £10,629,925.

| The parent undertaking and ultimate parent undertaking have confirmed that they will provide further financial support to the company as required to enable it to meet its liabilities as and when they fall due for at least twelve months from the date of approval of the financial statements of the company. Consequently, the financial statements have been prepared on a going concern basis.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Turnover is recognised on despatch at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Research & development costs

| Where research and development costs are capitalised, amortisation is provided at the following annual rate in order to write off each asset over its estimated useful life.

| Research and development costs - between 10% and 20% on cost

| Tangible fixed assets

| Tangible fixed assets are initially measured at cost. After initial recognition tangible fixed assets are measured at cost less accumulated depreciation and any impairment losses.

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Improvements to property - 10% on cost

| Plant and machinery - 20% on cost

| Fixtures and fittings - 10% on cost

| Office Equipment - 25% on cost

| Investments in subsidiaries

| Investments in subsidiary undertakings are initially recognised at cost. After initial recognition, investments in subsidiary undertakings are measured at cost less any accumulated impairment losses.

SCINOMED LTD (REGISTERED NUMBER: 06509477)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 29 DECEMBER 2025

2. | ACCOUNTING POLICIES - continued

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Cost is derived as the total free on board cost including freight charges.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| Debtors

| Short term debtors are measured at transaction price, less any impairment.

| Cash at bank and in hand

| Cash at bank and in hand represents cash and short-term highly liquid funds.

| Creditors

| Creditors are recognised when the company has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors are normally recognised at their settlement amount after allowing for any discounts due.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 6 (2024 - 6 ) .

SCINOMED LTD (REGISTERED NUMBER: 06509477)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 29 DECEMBER 2025

4. | INTANGIBLE FIXED ASSETS

| Other

| intangible

| assets

£ |

| COST

| At 30 December 2024 | 1,274,739 |  |

| Additions | 24,174 |  |

| At 29 December 2025 | 1,298,913 |  |

| AMORTISATION

| At 30 December 2024 | 731,169 |  |

| Charge for year | 127,707 |  |

| At 29 December 2025 | 858,876 |  |

| NET BOOK VALUE

| At 29 December 2025 | 440,037 |  |

| At 29 December 2024 | 543,570 |  |

5. | TANGIBLE FIXED ASSETS

| Improvements |  | Fixtures |

| to |  | Plant and |  | and |  | Office |

| property |  | machinery |  | fittings |  | Equipment |  | Totals

£ | £ | £ | £ | £ |

| COST

| At 30 December 2024 | 1,579 |  | 648,304 |  | 18,934 |  | 39,861 |  | 708,678 |  |

| Additions | - |  | 26,453 |  | - |  | 19,500 |  | 45,953 |  |

| Disposals | - |  | (2,062 | ) | - |  | - |  | (2,062 | ) |

| At 29 December 2025 | 1,579 |  | 672,695 |  | 18,934 |  | 59,361 |  | 752,569 |  |

| DEPRECIATION

| At 30 December 2024 | 1,579 |  | 204,091 |  | 12,392 |  | 34,616 |  | 252,678 |  |

| Charge for year | - |  | 92,810 |  | 1,590 |  | 7,797 |  | 102,197 |  |

| Eliminated on disposal | - |  | (962 | ) | - |  | - |  | (962 | ) |

| At 29 December 2025 | 1,579 |  | 295,939 |  | 13,982 |  | 42,413 |  | 353,913 |  |

| NET BOOK VALUE

| At 29 December 2025 | - |  | 376,756 |  | 4,952 |  | 16,948 |  | 398,656 |  |

| At 29 December 2024 | - |  | 444,213 |  | 6,542 |  | 5,245 |  | 456,000 |  |

SCINOMED LTD (REGISTERED NUMBER: 06509477)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 29 DECEMBER 2025

6. | FIXED ASSET INVESTMENTS

| Shares in

| group

| undertakings

£ |

| COST

| At 30 December 2024

| and 29 December 2025 | 1,965,656 |  |

| NET BOOK VALUE

| At 29 December 2025 | 1,965,656 |  |

| At 29 December 2024 | 1,965,656 |  |

7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade debtors | - |  | 29,296 |  |

| Amounts owed by group undertakings | 12,876,798 |  | 8,726,251 |  |

| Other debtors | 8,588 |  | 366,055 |  |

12,885,386 |  | 9,121,602 |  |

8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade creditors | 66,830 |  | 331,574 |  |

| Taxation and social security | 144,877 |  | 18,080 |  |

| Other creditors | 6,648 |  | 110,605 |  |

218,355 |  | 460,259 |  |

9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

2025 | 2024 |

£ | £ |

| Amounts owed to group undertakings | 26,455,817 |  | 24,323,373 |  |

| The loans are unsecured with no set repayment date. A market rate of interest is payable on the loans.

10. | CALLED UP SHARE CAPITAL

| Allotted and issued:

| Number: | Class: | Nominal | 2025 | 2024 |

| value: | £ | £ |

| 800,000 | Share capital 1 | £1 | 800,000 |  | 800,000 |  |

SCINOMED LTD (REGISTERED NUMBER: 06509477)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 29 DECEMBER 2025

11. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

| The Report of the Auditors was unqualified.

| Graham French (Senior Statutory Auditor)

| for and on behalf of DSC Accountants Ltd

12. | ULTIMATE CONTROLLING PARTY

| The controlling party is International Investments II Limited, a company incorporated in Hong Kong.